Insider Buying: Cyclopharm Limited (ASX:CYC) Insider Buys A$13,266.63 in Stock

Cyclopharm Limited (ASX:CYC) insider David Heaney acquired 8,874 shares of the firm’s stock in a transaction that occurred on Wednesday, February 26th. The stock was acquired at an average price of A$1.50 ($0.93) per share, with a total value of A$13,266.63 ($8,240.14).

Cyclopharm Price Performance

The firm has a market capitalization of $219.50 million, a PE ratio of -20.32 and a beta of 0.70. The company has a debt-to-equity ratio of 11.72, a quick ratio of 4.68 and a current ratio of 4.38.

About Cyclopharm

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. The company operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism.